<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE307nnn/GSE307390/</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307390</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>In situ fate mapping identifies the neonatal origin of platelet-biased hematopoietic stem cells</name><description>Hematopoietic stem cells (HSCs) display heritable and deterministic gene regulatory states associated with functional heterogeneity. However how these biased fate programs change through development remains poorly understood. Here, using single-cell lineage tracing, we map the function and state of thousands of individual mouse HSCs spanning from the earliest mature fetal stages until young adults. We identify a burst of platelet- and myeloid-biased HSCs during the first postnatal week. Fetal HSCs retain a fetal-like program even after 4 months in the recipient bone marrow, suggesting that the adult HSC program is epigenetically configured early after birth. Creating a single-cell atlas of mouse perinatal HSCs, we identify a transient HSC state with hallmarks of Epithelial-Mesenchymal Transition (EMT), mTOR complex 1 activity, and cholesterol synthesis (SREBP targets). Tracing the rare cells that traverse this transient state, we reveal the neonatal origin of long-term platelet/myeloid-biased HSCs in both native and transplantation hematopoiesis. Transient treatment with mTORC1 inhibitor rapamycin during the first postnatal week suffices to reduce the platelet-biased adult HSC programming, without affecting total HSC numbers. In sum, we reveal a late developmental origin for platelet-biased HSCs, with important implications for hematopoietic aging.</description><dates><publication>2026/09/01</publication></dates><accession>GSE307390</accession><cross_references><GSM>GSM9223254</GSM><GSM>GSM9223243</GSM><GSM>GSM9223265</GSM><GSM>GSM9223255</GSM><GSM>GSM9223244</GSM><GSM>GSM9223263</GSM><GSM>GSM9223252</GSM><GSM>GSM9223253</GSM><GSM>GSM9223264</GSM><GSM>GSM9223242</GSM><GSM>GSM9223250</GSM><GSM>GSM9223261</GSM><GSM>GSM9223251</GSM><GSM>GSM9223262</GSM><GSM>GSM9223260</GSM><GSM>GSM9223249</GSM><GSM>GSM9223258</GSM><GSM>GSM9223247</GSM><GSM>GSM9223248</GSM><GSM>GSM9223259</GSM><GSM>GSM9223245</GSM><GSM>GSM9223256</GSM><GSM>GSM9223257</GSM><GSM>GSM9223246</GSM><GPL>24247</GPL><GSE>307390</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>